BD Veritor™ At-Home and BD Veritor™ Professional

Inclusion Criteria: * 1\. Participants symptomatic of an acute respiratory illness within 7 DOSO * 2\. ≥2 years of age at the time of study participation * 3\. Symptomatic subjects with * a. Any one of the following symptoms (with or without additional symptoms): * i. Fever * 1\. Oral/temporal artery: ≥100.4 °F / ≥38.0 °C * 2\. Rectal/Ear: ≥101.2 °F / ≥38.5 °C * ii. Cough * iii. Malaise (fatigue/extreme tiredness) * b. Or two of the following symptoms: * i. Sore throat, * ii. Shortness of breath/difficult breathing * iii. Rhinorrhea (runny or stuffy nose), * iv. Myalgia, * v. Headache, * vi. Sneezing, * vii. New loss of taste or smell, * viii. One or more GI symptoms (nausea, vomiting, diarrhea) Exclusion Criteria: * 1\. Participants currently undergoing treatment and/or within the past thirty (30) days of the study, with medication to treat novel Coronavirus SARS-CoV-2 viral infections, which may include but is not limited to Remdesivir (Veklury) * 2\. Participants receiving convalescent plasma therapy for SARS-CoV-2. * 3\. Participants who have received antiviral medications for influenza within the previous 30 days. * 4\. Participants who have had a nasal wash or aspirate as part of their standard of care treatment on day of study visit. * 5\. The participant is currently receiving or has received within the past thirty (30) days of the study visit, an experimental biologic or drug including either treatment or therapy. * 6\. Participants who have been previously enrolled in the study. * 7\. History of frequent or difficult to control nosebleeds within the last fourteen (14) days. * 8\. Participants who have tested positive for Flu A/B or SARS-CoV-2 within the last 28 days (excluding the day of enrollment in the study). Exclusion criteria for the participation in the At-Home portion of the study would include all of the criteria previously listed and include the following * 1\. Participants without the ability to read or write in the English Language * 2\. Participants with prior medical or laboratory training.